FTC

FTC Unanimously Agrees to Keep Close Eye on PBMs, Higher Drug Costs
BioSpace
Mon, 06/20/22 - 10:27 am
FTC
PBMs
drug pricing
Pharma under the microscope as FTC considers new ways to review acquisitions
BioPharma Dive
Fri, 06/17/22 - 10:38 am
FTC
M&A
FTC targets insulin, threatening to go after PBM-pharma deals that steer into 'commercial bribery'
Endpoints
Fri, 06/17/22 - 10:04 am
FTC
insulin
diabetes
drug pricing
PBMs
Did J&J and BMS conspire on blood thinner price hikes? Congressional leaders want DOJ, FTC to look into it: report
Fierce Pharma
Tue, 06/14/22 - 08:57 pm
JNJ
Xarelto
Bristol Myers Squibb
Eliquis
drug pricing
blood thinners
FTC
FTC launches probe into pharmacy benefit management sector
Pharmaforum
Wed, 06/8/22 - 10:11 am
FTC
PBMs
drug pricing
Pile-on over PBMs continues with FTC comments and a new bipartisan Senate bill
Endpoints
Thu, 05/26/22 - 10:48 pm
FTC
PBMs
regulatory
Senate
Medtronic Hits an FTC Roadblock in Intersect ENT Deal
Medical Devices and Diagnostics Industry
Wed, 05/11/22 - 11:02 pm
Medtech
devices
Medtronic
FTC
M&A
Intersect ENT
FTC deadlocks on vote to launch study into PBM practices
BioPharma Dive
Fri, 02/18/22 - 10:33 am
FTC
PBMs
drug pricing
FTC plots a look into the competitive impact of PBMs on drug prices, pharmacies
Endpoints
Wed, 02/16/22 - 11:16 pm
FTC
PBMs
drug pricing
competition
Biogen says U.S. FTC, SEC probing Alzheimer's disease drug
Reuters
Mon, 02/7/22 - 11:26 pm
Biogen
Aduhelm
FTC
SEC
Alzheimer's disease
Merck Delays Acceleron Deal Amidst Continuing Stakeholder Criticism
BioSpace
Mon, 11/1/21 - 11:19 pm
Merck
Accerleron
M&A
FTC
DOJ
Martin Shkreli to go toe-to-toe with new FTC chair over Daraprim price spikes
Endpoints
Fri, 09/10/21 - 10:58 am
Martin Shkreli
FTC
drug pricing
Daraprim
fraud
Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028
Fierce Pharma
Tue, 09/7/21 - 10:43 pm
Bristol Myers Squibb
Pfizer
Eliquis
patents
FTC
Sanofi refiles $3.2B Translate Bio buyout with FTC to allow more time for review
Fierce Pharma
Tue, 08/31/21 - 10:06 pm
Sanofi
Translate Bio
M&A
FTC
Illumina purchases Grail without clearance from FTC or European Union
Stat
Wed, 08/18/21 - 11:32 pm
Illumina
DNA sequencing
M&A
Grail
FTC
EU
As AbbVie and Soliton shake hands on a $550M merger, the FTC says 'not so fast'
Endpoints
Wed, 08/11/21 - 12:14 pm
AbbVie
Soliton
Resonic
M&A
FTC
FTC drops AbbVie antitrust case, but fires a parting shot at the firm
Pharmaforum
Mon, 08/2/21 - 10:52 am
AbbVie
FTC
Androgel
competition
10 of the Most Controversial Deals in Medtech
Medical Devices and Diagnostics Industry
Sun, 07/18/21 - 10:28 pm
devices
Medtech
M&A
FTC
Illumina
Pacific Biosciences
Google
Fitbit
HeartWare
Thoratec
Strkyer
Wright Medical
Organovo
Tarveda Therapeutics
Thermofisher
Qiagen
Second Sight Medical
Pixium Vision
Medtronic
Covidien
Grail
Abbott Labs
Alere
Healthcare mergers, 'pay for delay' deals get added scrutiny under Biden order
BioPharma Dive
Sun, 07/11/21 - 10:55 pm
Joe Biden
DOJ
FTC
antitrust
M&A
pay-for-delay
Are pharma mergers bad for biotech?
Stat
Tue, 07/6/21 - 11:31 pm
FTC
M&A

Pages